|
Prognostic factor
|
AUC
|
95% CI
|
p
|
|---|
|
Bilaterality
|
|
Neutrophils
|
0.673
|
0.529–0.818
|
0.023*
|
|
Lymphocyte
|
0.537
|
0.401–0.673
|
0.629
|
|
NLR
|
0.601
|
0.466–0.735
|
0.185
|
|
LMR
|
0.505
|
0.372–0.639
|
0.943
|
|
MPV
|
0.569
|
0.402–0.737
|
0.362
|
|
PDW
|
0.509
|
0.357–0.661
|
0.904
|
|
Lymph node metastasis
|
|
Neutrophils
|
0.649
|
0.528–0.771
|
0.020*
|
|
Lymphocyte
|
0.550
|
0.424–0.676
|
0.436
|
|
NLR
|
0.603
|
0.479–0.726
|
0.109
|
|
LMR
|
0.575
|
0.450–0.700
|
0.242
|
|
MPV
|
0.516
|
0.390–0.642
|
0.802
|
|
PDW
|
0.519
|
0.393–0.646
|
0.763
|
|
Coexistence with Hashimoto’s thyroiditis
|
|
Neutrophils
|
0.528
|
0.377–0.680
|
0.771
|
|
Lymphocyte
|
0.575
|
0.411–0.739
|
0.444
|
|
NLR
|
0.594
|
0.460–0.727
|
0.339
|
|
LMR
|
0.640
|
0.462–0.818
|
0.152
|
|
MPV
|
0.736
|
0.584–0.888
|
0.016*
|
|
PDW
|
0.721
|
0.548–0.893
|
0.024*
|
|
Advanced TNM stage
|
|
Neutrophils
|
0.515
|
0.358–0.672
|
0.864
|
|
Lymphocyte
|
0.691
|
0.558–0.825
|
0.029*
|
|
NLR
|
0.653
|
0.505–0.801
|
0.081
|
|
LMR
|
0.680
|
0.545–0.815
|
0.040*
|
|
MPV
|
0.545
|
0.352–0.737
|
0.612
|
|
PDW
|
0.564
|
0.366–0.763
|
0.465
|
- AUC, area under the curve of ROC; NLR, neutrophil-to-lymphocyte ratio; LMR, lymphocyte-to-monocyte ratio; MPV, mean platelet volume; PDW, platelet distribution width
- The significance level was set at P < 0.05
- * Significant difference
